Detection ofBRAF,NRAS,KIT,GNAQ,GNA11andMAP2K1/2mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis-Reference-Cited by-同舟云学术

Detection ofBRAF,NRAS,KIT,GNAQ,GNA11andMAP2K1/2mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis

Published:2017-04-10 Issue:32 Volume:8 Page:52304-52320
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Emelyanova Marina¹,Ghukasyan Lilit¹,Abramov Ivan¹²,Ryabaya Oxana²,Stepanova Evgenia²,Kudryavtseva Anna¹³,Sadritdinova Asiya¹³,Dzhumakova Cholpon²,Belysheva Tatiana²,Surzhikov Sergey¹,Lyubchenko Lyudmila²,Zasedatelev Alexander¹²,Nasedkina Tatiana¹²

Affiliation:

1. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation

2. Blokhin Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russian Federation

3. P. Hertsen Moscow Oncology Research Institute, Moscow, Russian Federation

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dabrafenib for Pilocytic Astrocytoma With BRAF V599ins;JCO Precision Oncology;2024-05

2. Diagnostics of IDH1/2 Mutations in Intracranial Chondroid Tumors: Comparison of Molecular Genetic Methods and Immunohistochemistry;Diagnostics;2024-01-16

3. Biological Microarray for Detection of Somatic Mutations in the Genes of Isocitrate Dehydrogenase 1 and 2;Биоорганическая химия;2023-09-01

4. Biological Microarray for Detection of Somatic Mutations in the Genes of Isocitrate Dehydrogenase 1 and 2;Russian Journal of Bioorganic Chemistry;2023-08-21

5. Rapamycin synergizes the cytotoxic effects of MEK inhibitor binimetinib and overcomes acquired resistance to therapy in melanoma cell lines in vitro;Investigational New Drugs;2021-03-08